Use of the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) questionnaires for clinical decision-making and psychological referral in ophthalmic care: a multicentre observational study

Objectives The aim of this study was to evaluate the influence of anxiety and depression on clinician decision-making in patients suffering from chronic eye disease in ophthalmological clinical practice. Design and setting This multicentre observational study, in collaboration with the WHO, included ophthalmologists and their patients affected by chronic eye disease. States of anxiety and depression were screened with specific questionnaires, the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7), self-administered by patients before the visit. In the present analysis, we report data from three major eye care centres in Italy between 2021 and 2022. Primary and secondary outcomes To assess self-reported changes in ophthalmologists’ clinical approach (communication style and their clinical-therapeutic strategies) and decisions after knowing questionnaire scores (primary aim), and to analyse the PHQ-9 and GAD-7 scores in patients with chronic eye diseases (secondary aim). Results 41 ophthalmologists and 359 patients were included. The results from PHQ-9 and GAD-7 scores showed critical depression and anxiety status scores (PHQ-9 ≥5 and GAD-7 ≥10) in 258 patients. In 74% of cases, no actions were taken by the ophthalmologists based on these scores; in 26% of cases, they changed their clinical approach; and in 14% of cases, they referred the patients for psychological/psychiatric evaluation. Conclusions States of anxiety and depression affect many patients with chronic eye conditions and need to be detected and managed early to improve patients’ well-being. Providing ophthalmologists with knowledge of their patients’ psychological conditions can change the clinical management and attitude towards referral for a psychological evaluation. Further studies are needed to expand our knowledge of how to raise awareness among ophthalmologists regarding multimorbidity of patients suffering from chronic eye diseases in order to achieve better clinical outcomes.

[1]  H. Senra,et al.  Anxiety levels moderate the association between visual acuity and health-related quality of life in chronic eye disease patients , 2022, Scientific Reports.

[2]  Christopher M. Smith,et al.  A systematic meta-review of systematic reviews about interprofessional collaboration: facilitators, barriers, and outcomes , 2022, Journal of interprofessional care.

[3]  R. V. van Nispen,et al.  Barriers and facilitators to recognize and discuss depression and anxiety experienced by adults with vision impairment or blindness: a qualitative study , 2021, BMC Health Services Research.

[4]  E. Lucenteforte,et al.  Association Between Visual Impairment and Depression in Patients Attending Eye Clinics: A Meta-analysis. , 2021, JAMA ophthalmology.

[5]  Dipal Nagda,et al.  The functional burden of diabetic retinopathy in the United States , 2021, Graefe's Archive for Clinical and Experimental Ophthalmology.

[6]  S. Mariotti,et al.  Knowledge of patient emotional health status: impact on clinical care in glaucoma and retinal services , 2021, BMJ Open Ophthalmology.

[7]  S. Silverstein,et al.  Visual Impairment and Mental Health: Unmet Needs and Treatment Options , 2020, Clinical ophthalmology.

[8]  Yuqin Wang,et al.  Economic Hardship, Ocular Complications, and Poor Self-reported Visual Function are Predictors of Mental Problems in Patients with Uveitis , 2020, Ocular immunology and inflammation.

[9]  H. Jeon Correlation of physical, psychological, and functional factors with independent medication adherence in Korean older adults with chronic illness: Using the 2017 national survey of older Koreans. , 2020, Archives of gerontology and geriatrics.

[10]  Gianni Virgili,et al.  Low vision rehabilitation for better quality of life in visually impaired adults. , 2020, The Cochrane database of systematic reviews.

[11]  S. Hallit,et al.  Prevalence and factors affecting the level of depression, anxiety, and stress in hospitalized patients with a chronic disease. , 2019, Perspectives in psychiatric care.

[12]  R. Foster,et al.  Impact of Diabetic Retinopathy on Sleep, Mood, and Quality of Life , 2019, Investigative ophthalmology & visual science.

[13]  C. Nikendei,et al.  Psychological burden and resilience factors in patients with Alveolar Echinococcosis – A cross-sectional study , 2019, PLoS neglected tropical diseases.

[14]  G. V. van Rens,et al.  The incidence and predictors of depressive and anxiety symptoms in older adults with vision impairment: a longitudinal prospective cohort study , 2017, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[15]  A. L. Solebo,et al.  Epidemiology of blindness in children , 2017, Archives of Disease in Childhood.

[16]  K. Balaskas,et al.  Experience of Anti-VEGF Treatment and Clinical Levels of Depression and Anxiety in Patients With Wet Age-Related Macular Degeneration. , 2017, American journal of ophthalmology.

[17]  Xiaohang Wu,et al.  The Prevalence of Depression and Depressive Symptoms among Eye Disease Patients: A Systematic Review and Meta-analysis , 2017, Scientific Reports.

[18]  B. Rovner,et al.  Anxiety and depression in patients with advanced macular degeneration: current perspectives , 2015, Clinical ophthalmology.

[19]  M. Dessouky Disclaimer , 2015, 2020 20th International Conference on Advances in ICT for Emerging Regions (ICTer).

[20]  Bruce Guthrie,et al.  Visual impairment is associated with physical and mental comorbidities in older adults: a cross-sectional study , 2014, BMC Medicine.

[21]  T. Rosenberg,et al.  Prevalence of Generalized Retinal Dystrophy in Denmark , 2014, Ophthalmic epidemiology.

[22]  C. Mallen,et al.  The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study data , 2014, BMC Ophthalmology.

[23]  Gretchen A. Stevens,et al.  Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010. , 2013, Ophthalmology.

[24]  A. Mann,et al.  Detecting Depression in Patients with Coronary Heart Disease: a Diagnostic Evaluation of the PHQ-9 and HADS-D in Primary Care, Findings From the UPBEAT-UK Study , 2013, PloS one.

[25]  T. To,et al.  Assessing the Volume-Outcome Hypothesis and Region-Level Quality Improvement Interventions: Pancreas Cancer Surgery in Two Canadian Provinces , 2010, Annals of Surgical Oncology.

[26]  G. Brenes Anxiety, depression, and quality of life in primary care patients. , 2007, Primary care companion to the Journal of clinical psychiatry.

[27]  E. Kunkel,et al.  Psycho-oncology: Review and update , 2006, Current psychiatry reports.

[28]  open access to scientific and medical research Open Access Full Text Article , 1998 .